During the past decade, Eastbourne District General Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastbourne District General Hospital" #1 sponsor was "Eastbourne General Hospital" with 6 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Neil Sulke" with 3 trials sponsored and "East Sussex Hospitals NHS Trust" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastbourne District General Hospital" #1 collaborator was "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "British Heart Foundation" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Eastbourne District General Hospital" are "Atrial Fibrillation" (10 trials), "Breast Cancer" (5 trials), "Prostate Cancer" (5 trials), "Colorectal Cancer" (3 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Eastbourne District General Hospital" in a lesser frequency.

Most popular intervention types in "Eastbourne District General Hospital" are "Drug" (15 trials), "Procedure" (13 trials), "Device" (7 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "capecitabine" (3 trials), "adjuvant therapy" (2 trials), "cetuximab" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eastbourne District General Hospital" are 32 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Eastbourne District General Hospital". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Eastbourne District General Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eastbourne District General Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".